Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phytochemicals: Current strategy to sensitize cancer cells to cisplatin
Chao‐Yue Sun, Qian-Yu Zhang, Guangjuan Zheng, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 110, pp. 518-527
Open Access | Times Cited: 110

Showing 1-25 of 110 citing articles:

Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer
Jian-Shu Lou, Li-Ping Zhao, Zhi-Hui Huang, et al.
Phytomedicine (2020) Vol. 80, pp. 153370-153370
Closed Access | Times Cited: 282
A green and sensitive guanine-based DNA biosensor for idarubicin anticancer monitoring in biological samples: A simple and fast strategy for control of health quality in chemotherapy procedure confirmed by docking investigation
Hassan Karimi‐Maleh, Alireza Khataee, Fatemeh Karimi, et al.
Chemosphere (2021) Vol. 291, pp. 132928-132928
Closed Access | Times Cited: 277
Cisplatin for cancer therapy and overcoming chemoresistance
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Heliyon (2022) Vol. 8, Iss. 9, pp. e10608-e10608
Open Access | Times Cited: 75
Metformin modified chitosan as a multi-functional adjuvant to enhance cisplatin-based tumor chemotherapy efficacy
Zaigang Zhou, Yu Liu, Xin Jiang, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 797-809
Closed Access | Times Cited: 70
Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New Solutions
Aleksandra Zoń, Ilona Bednarek
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7585-7585
Open Access | Times Cited: 64
Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives
Elina Khatoon, Kishore Banik, Choudhary Harsha, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 306-339
Closed Access | Times Cited: 121
Microneedles for gene and drug delivery in skin cancer therapy
Defu Zhi, Ting Yang, Tingyu Zhang, et al.
Journal of Controlled Release (2021) Vol. 335, pp. 158-177
Closed Access | Times Cited: 76
Molecular Targets of Natural Compounds with Anti-Cancer Properties
Małgorzata Kubczak, Aleksandra Szustka, Małgorzata Rogalińska
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13659-13659
Open Access | Times Cited: 76
Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer
Mahesh P. More, Sagar R. Pardeshi, Chandrakantsing V. Pardeshi, et al.
Medicine in Drug Discovery (2021) Vol. 10, pp. 100082-100082
Open Access | Times Cited: 70
BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism
Lifang Luo, Wenjing Sun, Weijian Zhu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 62
Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity
Ivan K. Domingo, Asna Latif, Amit P. Bhavsar
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7227-7227
Open Access | Times Cited: 46
Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer
Dzohara Murillo, Carmen Huergo, Borja Gallego, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 208-208
Open Access | Times Cited: 39
Synthesis, characterization, biological and docking studies of ZrO(II), VO(II) and Zn(II) complexes of a halogenated tetra-dentate Schiff base
Laila H. Abdel‐Rahman, Mohamed Shaker S. Adam, Nabil Al‐Zaqri, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 5, pp. 103737-103737
Open Access | Times Cited: 38
Hibiscus-cisplatin combination treatment decreases liver toxicity in rats while increasing toxicity in lung cancer cells via oxidative stress- apoptosis pathway
Alaaeldin Ahmed Hamza, Gehan H. Heeba, Soha Osama Hassanin, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115148-115148
Open Access | Times Cited: 34
Hyaluronic Acid-Modified Cisplatin-Encapsulated Poly(Lactic-co-Glycolic Acid) Magnetic Nanoparticles for Dual-Targeted NIR-Responsive Chemo-Photothermal Combination Cancer Therapy
Huai‐An Chen, Yu‐Jen Lu, Banendu Sunder Dash, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 290-290
Open Access | Times Cited: 25
Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review
Bethsebie Lalduhsaki Sailo, Le Liu, Suravi Chauhan, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 244-244
Open Access | Times Cited: 13
Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment
Chuansheng Yang, Xinpei Deng, Yunyun Tang, et al.
Cancer Letters (2024) Vol. 598, pp. 217116-217116
Closed Access | Times Cited: 8
Targeting STAT3 inhibition to reverse cisplatin resistance
Chao‐Yue Sun, Juan Nie, Jie-Peng Huang, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 117, pp. 109135-109135
Open Access | Times Cited: 72
CircRNA_101505 sensitizes hepatocellular carcinoma cells to cisplatin by sponging miR-103 and promotes oxidored-nitro domain-containing protein 1 expression
Yanwei Luo, Yunfeng Fu, Rong Huang, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 71
Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells
Zahra Hasanpoor, Ali Mostafaie, Iraj Nikokar, et al.
International Journal of Biological Macromolecules (2020) Vol. 159, pp. 137-153
Closed Access | Times Cited: 51
Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients
Nalini Devarajan, Reji Manjunathan, Senthil Kumar Ganesan
Critical Reviews in Oncology/Hematology (2021) Vol. 162, pp. 103327-103327
Closed Access | Times Cited: 45
Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition
Jingjing Sha, Yunpeng Bai, Huy Ngo, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 893-893
Open Access | Times Cited: 44
Cisplatin Resistance in Cancer Therapy: Causes and Overcoming Strategies
S Shruthi, K. Bhasker Shenoy
ChemistrySelect (2024) Vol. 9, Iss. 25
Closed Access | Times Cited: 7
A novel platform for drug testing: Biomimetic three-dimensional hyaluronic acid-based scaffold seeded with human hepatocarcinoma cells
Mihaela Turtoi, Maria Anghelache, Sanda-Maria Bucătariu, et al.
International Journal of Biological Macromolecules (2021) Vol. 185, pp. 604-619
Open Access | Times Cited: 34
Synergy, Additivity, and Antagonism between Cisplatin and Selected Coumarins in Human Melanoma Cells
Paula Wróblewska-Łuczka, Aneta Grabarska, Magdalena Florek-Łuszczki, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 537-537
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top